Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-063061

Chief Executive Officer acquired 34,789 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-30 Exercise or conversion : show line 1 in the form +34,789 425,952 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-30 Exercise or conversion : show line 2 in the form Restricted Stock Units −34,789 521,831 D
Loading xslF345X05/ownership.xml…